Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Screening for reducing morbidity and mortality in malignant melanoma.

Johansson M, Brodersen J, Gøtzsche PC, Jørgensen KJ.

Cochrane Database Syst Rev. 2019 Jun 3;6:CD012352. doi: 10.1002/14651858.CD012352.pub2. Review.

PMID:
31157404
2.

General health checks in adults for reducing morbidity and mortality from disease.

Krogsbøll LT, Jørgensen KJ, Gøtzsche PC.

Cochrane Database Syst Rev. 2019 Jan 31;1:CD009009. doi: 10.1002/14651858.CD009009.pub3.

PMID:
30699470
3.

Screening for abdominal aortic aneurysm - Authors' reply.

Johansson M, Zahl PH, Siersma V, Jørgensen KJ, Marklund B, Brodersen J.

Lancet. 2019 Jan 5;393(10166):28. doi: 10.1016/S0140-6736(18)32742-9. No abstract available.

PMID:
30614454
4.

Should we screen women for abdominal aortic aneurysm?

Johansson M, Jørgensen KJ.

Lancet. 2018 Aug 11;392(10146):454-456. doi: 10.1016/S0140-6736(18)31438-7. Epub 2018 Jul 26. No abstract available.

5.

Benefits and harms of screening men for abdominal aortic aneurysm in Sweden: a registry-based cohort study.

Johansson M, Zahl PH, Siersma V, Jørgensen KJ, Marklund B, Brodersen J.

Lancet. 2018 Jun 16;391(10138):2441-2447. doi: 10.1016/S0140-6736(18)31031-6.

PMID:
29916384
6.

Drawing conclusions from the VIVA trial.

Jørgensen KJ, Johansson M.

Lancet. 2018 May 12;391(10133):1894. doi: 10.1016/S0140-6736(18)30786-4. Epub 2018 May 10. No abstract available.

PMID:
29781439
7.

Melanoma Screening.

Jørgensen KJ.

Dermatology. 2017;233(5):410-411. doi: 10.1159/000484948. Epub 2017 Dec 15. No abstract available.

8.

Reform of the National Screening Mammography Program in France.

Barratt A, Jørgensen KJ, Autier P.

JAMA Intern Med. 2018 Feb 1;178(2):177-178. doi: 10.1001/jamainternmed.2017.5836. Review. No abstract available.

PMID:
29084317
9.

Breast Cancer Screening in Denmark.

Jørgensen KJ, Gøtzsche PC, Kalager M, Zahl PH.

Ann Intern Med. 2017 Oct 3;167(7):524. doi: 10.7326/L17-0270. No abstract available.

PMID:
28973200
10.

The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.

Boesen K, Saiz LC, Erviti J, Storebø OJ, Gluud C, Gøtzsche PC, Jørgensen KJ.

Evid Based Med. 2017 Aug;22(4):143-147. doi: 10.1136/ebmed-2017-110716. Epub 2017 Jul 13.

11.

National clinical guidelines for non-surgical treatment of patients with recent onset neck pain or cervical radiculopathy.

Kjaer P, Kongsted A, Hartvigsen J, Isenberg-Jørgensen A, Schiøttz-Christensen B, Søborg B, Krog C, Møller CM, Halling CMB, Lauridsen HH, Hansen IR, Nørregaard J, Jørgensen KJ, Hansen LV, Jakobsen M, Jensen MB, Melbye M, Duel P, Christensen SW, Povlsen TM.

Eur Spine J. 2017 Sep;26(9):2242-2257. doi: 10.1007/s00586-017-5121-8. Epub 2017 May 18. Review.

PMID:
28523381
12.

Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.

Jørgensen KJ, Gøtzsche PC, Kalager M, Zahl PH.

Ann Intern Med. 2017 Mar 7;166(5):313-323. doi: 10.7326/M16-0270. Epub 2017 Jan 10.

PMID:
28114661
13.

Overview of guidelines on breast screening: Why recommendations differ and what to do about it.

Jørgensen KJ, Kalager M, Barratt A, Baines C, Zahl PH, Brodersen J, Harris RP.

Breast. 2017 Feb;31:261-269. doi: 10.1016/j.breast.2016.08.002. Epub 2016 Oct 4. Review.

PMID:
27717717
14.

Authors' reply to Timms and Bird.

Johansson M, Jørgensen KJ, Getz L, Moynihan R.

BMJ. 2016 Aug 15;354:i4362. doi: 10.1136/bmj.i4362. No abstract available.

PMID:
27528539
15.

The benefits of screening--and its harms.

Johansson M, Jørgensen KJ, Brodersen J.

Lancet. 2016 Aug 6;388(10044):563-4. doi: 10.1016/S0140-6736(16)31219-3. No abstract available.

PMID:
27511784
16.

"Informed choice" in a time of too much medicine-no panacea for ethical difficulties.

Johansson M, Jørgensen KJ, Getz L, Moynihan R.

BMJ. 2016 May 9;353:i2230. doi: 10.1136/bmj.i2230. No abstract available.

PMID:
27160274
17.

Do invitations for cervical screening provide sufficient information to enable informed choice? A cross-sectional study of invitations for publicly funded cervical screening.

Kolthoff SK, Hestbech MS, Jørgensen KJ, Brodersen J.

J R Soc Med. 2016 Jul;109(7):274-81. doi: 10.1177/0141076816643324. Epub 2016 Apr 26.

18.

Breast Cancer Screening: Benefit or Harm?

Jørgensen KJ, Gøtzsche PC.

JAMA. 2016 Apr 5;315(13):1402. doi: 10.1001/jama.2015.19126. No abstract available.

PMID:
27046370
19.

[Flawed report on screening for abdominal aortic aneurysm--redo!].

Johansson M, Jørgensen KJ, Marklund B, Hansson A, Brodersen J.

Lakartidningen. 2016 Jan 25;113. pii: DU6S. Swedish. No abstract available.

20.

Cognitive behavioural therapy for ADHD in adults: systematic review and meta-analyses.

Jensen CM, Amdisen BL, Jørgensen KJ, Arnfred SM.

Atten Defic Hyperact Disord. 2016 Mar;8(1):3-11. doi: 10.1007/s12402-016-0188-3. Epub 2016 Jan 22. Review.

PMID:
26801998
21.

Breast cancer: Updated screening guidelines - much ado about small improvements.

Jørgensen KJ, Gøtzsche PC.

Nat Rev Clin Oncol. 2016 Mar;13(3):139-40. doi: 10.1038/nrclinonc.2015.232. Epub 2015 Dec 31. No abstract available.

PMID:
26718110
22.
23.

Harms of screening for abdominal aortic aneurysm: is there more to life than a 0.46% disease-specific mortality reduction?

Johansson M, Jørgensen KJ, Brodersen J.

Lancet. 2016 Jan 16;387(10015):308-10. doi: 10.1016/S0140-6736(15)00472-9. Epub 2015 Oct 22. No abstract available.

PMID:
26474807
24.

Treatment for women with postpartum iron deficiency anaemia.

Markova V, Norgaard A, Jørgensen KJ, Langhoff-Roos J.

Cochrane Database Syst Rev. 2015 Aug 13;(8):CD010861. doi: 10.1002/14651858.CD010861.pub2. Review.

PMID:
26270434
25.

[Bad aftertaste of drug lunch].

Johansson M, Jørgensen KJ.

Lakartidningen. 2015 Jun 15;112. pii: DICC. Swedish. No abstract available.

26.

Author reply: To PMID 24935281.

Kessel L, Tendal B, Jørgensen KJ, Erngaard D, Flesner P, Andresen JL, Hjortdal J.

Ophthalmology. 2015 Jun;122(6):e35-6. doi: 10.1016/j.ophtha.2014.11.028. No abstract available.

PMID:
26008912
27.

Effectiveness of pulmonary rehabilitation in COPD with mild symptoms: a systematic review with meta-analyses.

Rugbjerg M, Iepsen UW, Jørgensen KJ, Lange P.

Int J Chron Obstruct Pulmon Dis. 2015 Apr 17;10:791-801. doi: 10.2147/COPD.S78607. eCollection 2015. Review.

28.

A combination of resistance and endurance training increases leg muscle strength in COPD: An evidence-based recommendation based on systematic review with meta-analyses.

Iepsen UW, Jørgensen KJ, Ringbæk T, Hansen H, Skrubbeltrang C, Lange P.

Chron Respir Dis. 2015 May;12(2):132-45. doi: 10.1177/1479972315575318. Epub 2015 Mar 12. Review.

29.

A Systematic Review of Resistance Training Versus Endurance Training in COPD.

Iepsen UW, Jørgensen KJ, Ringbaek T, Hansen H, Skrubbeltrang C, Lange P.

J Cardiopulm Rehabil Prev. 2015 May-Jun;35(3):163-72. doi: 10.1097/HCR.0000000000000105. Review.

PMID:
25692720
30.

Danish evidence-based clinical guideline for use of nutritional support in pulmonary rehabilitation of undernourished patients with stable COPD.

Beck AM, Iepsen UW, Tobberup R, Jørgensen KJ.

Clin Nutr ESPEN. 2015 Feb;10(1):e33-e41. doi: 10.1016/j.clnme.2014.11.003. Epub 2014 Nov 15.

PMID:
28531445
31.

Screening with urinary dipsticks for reducing morbidity and mortality.

Krogsbøll LT, Jørgensen KJ, Gøtzsche PC.

Cochrane Database Syst Rev. 2015 Jan 28;1:CD010007. doi: 10.1002/14651858.CD010007.pub2. Review.

PMID:
25626128
32.

Author reply: To PMID 24935281.

Kessel L, Tendal B, Jørgensen KJ, Erngaard D, Flesner P, Andresen JL, Hjortdal J.

Ophthalmology. 2015 Feb;122(2):e17. doi: 10.1016/j.ophtha.2014.08.004. No abstract available.

PMID:
25618434
33.

Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care.

Aabenhus R, Jensen JU, Jørgensen KJ, Hróbjartsson A, Bjerrum L.

Cochrane Database Syst Rev. 2014 Nov 6;(11):CD010130. doi: 10.1002/14651858.CD010130.pub2. Review.

PMID:
25374293
34.

Lead-time models produce far too low estimates of overdiagnosis with mammographic screening.

Gøtzsche PC, Jørgensen KJ, Zahl PH.

J Am Coll Radiol. 2014 Nov;11(11):1098. doi: 10.1016/j.jacr.2014.08.008. Epub 2014 Oct 7. No abstract available.

PMID:
25301416
35.

The balance is shifting away from screening.

Brodersen J, Jørgensen KJ.

Clin Adv Hematol Oncol. 2014 Jun;12(6):407-9. No abstract available.

PMID:
25134177
36.

Authors' reply to Lauritzen and colleagues, Newton and colleagues, and Mangin.

Gøtzsche PC, Jørgensen KJ, Krogsbøll LT.

BMJ. 2014 Jul 30;349:g4790. doi: 10.1136/bmj.g4790. No abstract available.

PMID:
25078532
37.

Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review.

Kessel L, Tendal B, Jørgensen KJ, Erngaard D, Flesner P, Andresen JL, Hjortdal J.

Ophthalmology. 2014 Oct;121(10):1915-24. doi: 10.1016/j.ophtha.2014.04.035. Epub 2014 Jun 14. Review.

38.

General health checks don't work.

Gøtzsche PC, Jørgensen KJ, Krogsbøll LT.

BMJ. 2014 Jun 9;348:g3680. doi: 10.1136/bmj.g3680. No abstract available.

PMID:
24912801
39.

Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications.

Maund E, Tendal B, Hróbjartsson A, Jørgensen KJ, Lundh A, Schroll J, Gøtzsche PC.

BMJ. 2014 Jun 4;348:g3510. doi: 10.1136/bmj.g3510. Review.

40.

Influence of mammography screening on use of mastectomies in Denmark.

Jørgensen KJ, Zahl PH, Gøtzsche PC.

Acta Oncol. 2015 Jan;54(1):133-4. doi: 10.3109/0284186X.2014.920958. Epub 2014 Jun 1. No abstract available.

PMID:
24881500
41.

Lead-time models should not be used to estimate overdiagnosis in cancer screening.

Zahl PH, Jørgensen KJ, Gøtzsche PC.

J Gen Intern Med. 2014 Sep;29(9):1283-6. doi: 10.1007/s11606-014-2812-2. Epub 2014 Mar 4. Review.

42.

Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.

Jørgensen KJ, Gøtzsche PC, Dalbøge CS, Johansen HK.

Cochrane Database Syst Rev. 2014 Feb 24;(2):CD004707. doi: 10.1002/14651858.CD004707.pub3. Review.

43.

[Is the screening program for colorectal cancer outdated before it has begun?].

Jørgensen KJ.

Ugeskr Laeger. 2013 Nov 18;175(47):2900-1. Danish. No abstract available.

PMID:
26504935
44.

Universal health checks should be abandoned.

Krogsbøll LT, Jørgensen KJ, Gøtzsche PC.

BMJ. 2013 Sep 4;347:f5227. doi: 10.1136/bmj.f5227. No abstract available.

PMID:
24004991
45.

General health checks in adults for reducing morbidity and mortality from disease.

Krogsbøll LT, Jørgensen KJ, Gøtzsche PC.

JAMA. 2013 Jun 19;309(23):2489-90. doi: 10.1001/jama.2013.5039.

PMID:
23780462
46.

Screening for breast cancer with mammography.

Gøtzsche PC, Jørgensen KJ.

Cochrane Database Syst Rev. 2013 Jun 4;(6):CD001877. doi: 10.1002/14651858.CD001877.pub5. Review.

47.

The benefits and harms of breast cancer screening.

Gøtzsche PC, Jørgensen KJ.

Lancet. 2013 Mar 9;381(9869):799. doi: 10.1016/S0140-6736(13)60618-2. Epub 2013 Mar 8. No abstract available.

PMID:
23668503
48.

Mammography screening. Benefits, harms, and informed choice.

Jørgensen KJ.

Dan Med J. 2013 Apr;60(4):B4614. Review.

PMID:
23651722
49.

Overdiagnosis of breast cancer in Norway: what have the authors adjusted for?

Zahl PH, Suhrke P, Jørgensen KJ.

Int J Cancer. 2013 Dec 1;133(11):2754-5. doi: 10.1002/ijc.28248. Epub 2013 May 29. No abstract available.

50.

Citations of scientific results and conflicts of interest: the case of mammography screening.

Rasmussen K, Jørgensen KJ, Gøtzsche PC.

Evid Based Med. 2013 Jun;18(3):83-9. doi: 10.1136/eb-2012-101216. Epub 2013 May 1.

Supplemental Content

Loading ...
Support Center